Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |